Abstract | BACKGROUND: hRad9 is a cell cycle checkpoint gene that is up-regulated in breast cancer. We have previously shown that the mRNA up-regulation correlated with tumor size and local recurrence. Immunohistochemical studies were made to better define the role of hRad9 in breast carcinogenesis. METHODS: Localisation of hRad9 protein were performed on paired tumor and normal breast tissues. Immunoblotting with and without dephosphorylation was used to define the protein isolated from breast cancer cells. RESULTS: CONCLUSION: Finding of hyperphosphorylated forms of hRad9 in the nucleus of cancer cells is in keeping with its function in ameliorating DNA instability, whereby it inadvertently assists tumor growth.
|
Authors | Vivian Chan, U S Khoo, M S Wong, Ken Lau, Dacita Suen, George Li, Ava Kwong, T K Chan |
Journal | BMC cancer
(BMC Cancer)
Vol. 8
Pg. 196
(Jul 11 2008)
ISSN: 1471-2407 [Electronic] England |
PMID | 18616832
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Cell Cycle Proteins
- Protein Isoforms
- Transcription Factors
- rad9 protein
- Phosphotransferases
|
Topics |
- Breast Neoplasms
(genetics, pathology)
- Carcinoma
(genetics, pathology)
- Cell Cycle Proteins
(biosynthesis, genetics)
- Cell Transformation, Neoplastic
(genetics)
- DNA Repair
(genetics)
- Female
- Gene Expression Regulation, Neoplastic
- Humans
- Immunohistochemistry
- Mammary Glands, Human
(metabolism)
- Organ Specificity
- Phosphorylation
- Phosphotransferases
(genetics, metabolism)
- Protein Isoforms
(biosynthesis)
- Transcription Factors
(biosynthesis, genetics)
- Transcriptional Activation
|